Skip to content

UK man's HIV 'cure' premature and unsubstantiated

High incidence of TB after ART started, MSF reports

CD4 percentage could help decide when to start treatment

Routine lactate monitoring warranted only in those at risk, concludes Swiss study

Lower CD4 cell count in Ethiopians doesn't mean shorter survival

IAS: $7 viral load test equivalent to more expensive high tech viral load tests, Malawi study shows

IAS: WHO clinical staging excluding many without symptoms from HIV treatment, despite need

IAS: Two studies suggest that it may be possible to screen for acute primary HIV infections in sub-Saharan Africa

Microchip could bring CD4 cell counting to poorest countries